Esther Rajavelu - Nov 13, 2023 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Chief Financial Officer and Chief Business Officer
Signature
/s/ Tamara Joseph, Attorney-in-Fact for Esther Rajavelu
Stock symbol
SPRO
Transactions as of
Nov 13, 2023
Transactions value $
$0
Form type
4
Date filed
11/15/2023, 04:17 PM
Previous filing
Nov 15, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +300K $0.00 300K Nov 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on November 6, 2024, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

Chief Financial Officer and Chief Business Officer